Abstract
ILLUMINATE-C, a Single-Arm, Phase 3 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 and CKD Stages 3b-5, Including Those on Hemodialysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have